Pluristem Therapeutics Inc.

Company Name:
Pluristem Therapeutics Inc. 
Transaction Type:
Follow-on Offering 
Ticker Symbol:
Deal Amount:
Transaction Date:
Transaction Summary:
Pluristem Therapeutics Inc. raised $36.8 million in its follow-on offering at $4.00 per unit, with each unit consisting of one share of the company's common stock and one warrant to purchase 0.35 of a share of the company's common stock. Needham acted as a co-manager on the transaction. The Company‚Äôs underwriters fully exercised their option to purchase an additional 1,200,000 shares of common stock at the follow-on offering price to cover over-allotments. The net proceeds from the sale of the shares from the offering will be used by Pluristem Therapeutics Inc. to fund the preparation and conduct of its clinical studies, research and product development activities, and for general corporate purposes, including working capital and administrative expenses. 
Company Description:
Pluristem Therapeutics Inc. (NASDAQ: PSTI) (TASE: PLTR) is a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe inflammatory and ischemic disorders.  
Investment Banking